ArticleBrain communications2025

Association between amyloid-β42 levels and neuropsychiatric symptoms in Alzheimer's disease trials.

Jesus Thomas Abanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.